Levan Darjania Email & Phone Number
Sr. Director, DMPK @ BlossomHill Therapeutics, Inc.
5 free lookup(s).
If you need more lookups,
subscriptions start at $34 USD/month.
Levan Darjania Location
- San Diego, CA, US
Levan Darjania Work
- 2023 -now Sr. Director, DMPK @
- 2020 -2023 Director, DMPK @
- 2017 -2020 Vice President (Project Analysis and Global R and D) @ MJNA Investment Group, LLC.
- 2013 -2017 Director (DMPK) @ Wellspring Biosciences, LLC. (Johnson & Johnson Pharmaceutical)
- 2012 -2013 Sr. Principal Scientist (Analytical Chemistry and DMPK) @
- 2009 -2012 Pre-Clinical Development, DMPK Group Leader @ Intellikine Inc. - (acquired by Takeda Pharmaceuticals)
- 2005 -2009 Head, Preclinical DMPK @ Cylene Pharmaceuticals, Inc., (Acquired by Senhwa Biosciences)
- 2003 -2005 Sr. Scientist, DMPK @
- 2001 -2003 Sr. Scientist (Bioanalytical) @ Alerion Biomedical, Inc (California Institute of Technology) - Acquired by ART A
- 1997 -2001 Post-Doctoral Researcher, Prof. Dr. Guy A. Thompson Jr. Laboratory @
- 1993 -1996 Principal Research Investigator @ CERZOS-CONICET - ARGENTINA
- 1991 -1993 Visiting Professor @
Levan Darjania Education
- The University of Texas at Austin
Post-Doctoral (Biochemisty, Bioanalysis)
1997-2001 - A.N. Bach Institute of Biochemistry, Aademy of Sciences, Moscow - former USSR
PhD (Biochemistry)
1984-1989
Levan Darjania Skills
- Biomedical Research
- Cancer Therapeutics
- Market Analysis
- From Conception to Completion
- Research Planning
- Industry standards
- Strategic Initiatives
- Research Project Management
- Cross-functional Team Leadership
- Applied Research
- Bioanalytical Chemistry
- Strategic Leadership
- Regulatory Compliance
- Clinical Pharmacology
- Pharmacology
- Problem Solving
- Data Analysis
- Toxicology
- Cross-functional Collaborations
- Communication
- Key Opinion Leaders
- Candidate Selection
- Chemistry
- Neuroscience
- Early Development
- Instrumentation
- Pharmacokinetics
- Drug Metabolism
- Bioanalysis
- DMPK
- Biotechnology
- LC-MS
- Drug Development
- ADME
- Assay Development
- Drug Discovery
- In Vitro
- Lipid Metabolism
- Peptide analysis
- Biochemistry
- GLP
- Biopharmaceuticals
- Clinical Development
- Oncology
- Pharmaceutical Industry
- Protein Chemistry
- High-Performance Liquid Chromatography (HPLC)
- Mass Spectrometry
- Research and Development (R&D)
- CRO Management
- U.S. Food and Drug Administration (FDA)
- Analytical Chemistry
- Clinical Trials
- PK/PD
- Bioavailability
- Drug Delivery
- Regulatory Submissions
- Regulatory Affairs
- Regulatory Guidlines
- Presentation Skills
- Small Molecules
- Clinical Research
- Customer Service
- Lc Ms
- GI
- Consulting
- Chemical
- Trap
- In Vivo
- Argentina
- Net
- Students
- Renewable Resources
- Veterinary
- LCMS
- Access Control
- Cascade
- Data Mapping
- Proliferation
- CX
- Functional Imaging
- ACD
- Data Profiling
- Lipids
- Quantification
- Particle
- APIs
- Dynamics
- Dionex
- Controlled Release
- Disease
- Acid
- Texas
- Management
- Simulations
- Design
- Feasibility Studies
- PC
- Peptides
- Outsourcing
- Patents
- Sop
- Spanish
- Regulators
- Toxicokinetics
- Blood
- Cros
- Georgia
- Dependent
- Languages
- Cell
- English
- Validation
- Membrane
- Winnonlin
- Reports
- Method Development
- Algae
- Gc Ms
- Microsoft Office
- Pesticide
- Corporations
- Training
- Sds
- Plasma Physics
- Solution
- Admet
- Hepatocytes
- Project Management
- American
- Research
- Chemists
- System Monitoring
- Solubility
- Commercial Real Estate
- Investigation
- Permeability
- R&d
- Contrast Agents
- Analysis
- Chemstation
- Automation
- Toxins
- Mechanisms
- Private Investment
- Business Partnering
- Metabolism
- Ion
- Omega
- Signal Transduction
- Moscow
- Tk
- Business Applications
- Enzymes
- Composition
- Buffer
- Proteomics
- FIX Protocol
- Tissue
- Scientific Review
- Business Expansion
- Carbohydrate
- Modeling
- Russia
- Scientific
- Safety
- Nano
- Digital Imaging
- Operations
- Characterization
- Purification
- Masslynx
- High Throughput
- Bioequivalence
- Scalability
- Mass Balance
- Project
- Adsorption
- Sequence Analysis
- MRI
- Technology Transfer
- Liver
- Quantitation
- Mdl
- Targeted Advertising
- Regulations
- Labelling
- Well Rounded
- Distribution
- Camp
- Georgian
- CRO
- Lead Development
- Biology
- HEV
- Russian
- Letters of Credit
- Treating
- Investments
- ICH guidelines
- Flux
- Diagnostics
- FPLC
- San Diego
- Mac
- Dissolution
- Bioassay
- Pharmaceutics
- Structural Engineering
- Group Development
- Matrices
- HCV
- Stability
- Tox
- Antiviral
- Formulation
- Optimization
- Scientists
- Esi Ms
- Research Projects
- Delivery
- Mergers and Acquisitions
- Evaluation
- Maldi Tof
- Research and Development
- Life Sciences
- High Performance Liquid Chromatography
- u.s. Food and Drug Administration
Levan Darjania Summary
- Levan Darjania, based in San Diego, CA, US, is currently a Sr. Director, DMPK at BlossomHill Therapeutics, Inc.. Levan Darjania brings experience from previous roles at Neurocrine Biosciences, MJNA Investment Group, LLC., Wellspring Biosciences, LLC. (Johnson & Johnson Pharmaceutical) and Takeda Pharmaceuticals. Levan Darjania holds a 1997 - 2001 Post-Doctoral in Biochemisty, Bioanalysis @ The University of Texas at Austin. With a robust skill set that includes Biomedical Research, Cancer Therapeutics, Market Analysis, From Conception to Completion, Research Planning and more. Levan Darjania has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Levan Darjania?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co